{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.500","meta":{"versionId":"11","lastUpdated":"2023-04-03T13:49:24.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CancerLinQ Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-04-03"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.500","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.500"}],"version":"20180721","name":"CytogeneticTestingPerformed","title":"Cytogenetic Testing Performed","status":"active","experimental":false,"date":"2018-07-21T01:00:04-04:00","publisher":"CancerLinQ Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","concept":[{"code":"3155F","display":"Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM)"},{"code":"88271","display":"Molecular cytogenetics; DNA probe, each (eg, FISH)"},{"code":"88272","display":"Molecular cytogenetics; chromosomal in situ hybridization, analyze 3-5 cells (eg, for derivatives and markers)"},{"code":"88273","display":"Molecular cytogenetics; chromosomal in situ hybridization, analyze 10-30 cells (eg, for microdeletions)"},{"code":"88274","display":"Molecular cytogenetics; interphase in situ hybridization, analyze 25-99 cells"},{"code":"88275","display":"Molecular cytogenetics; interphase in situ hybridization, analyze 100-300 cells"},{"code":"88291","display":"Cytogenetics and molecular cytogenetics, interpretation and report"},{"code":"88299","display":"Unlisted cytogenetic study"}]}]},"expansion":{"identifier":"urn:uuid:b67984bb-fa48-4b82-b025-c7f8304fad20","timestamp":"2023-12-10T21:41:32-05:00","total":8,"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"3155F","display":"Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"88271","display":"Molecular cytogenetics; DNA probe, each (eg, FISH)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"88272","display":"Molecular cytogenetics; chromosomal in situ hybridization, analyze 3-5 cells (eg, for derivatives and markers)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"88273","display":"Molecular cytogenetics; chromosomal in situ hybridization, analyze 10-30 cells (eg, for microdeletions)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"88274","display":"Molecular cytogenetics; interphase in situ hybridization, analyze 25-99 cells"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"88275","display":"Molecular cytogenetics; interphase in situ hybridization, analyze 100-300 cells"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"88291","display":"Cytogenetics and molecular cytogenetics, interpretation and report"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"88299","display":"Unlisted cytogenetic study"}]}}